Sarepta Gene Therapy Deaths - Search News

Order byBest matchMost fresh

News

US FDA Investigates 3rd Death

· 9h · on MSN

FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy

The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who received Sarepta Therapeutics' muscular disorder gene therapy Elevidys. The death occurred on June 7,

Continue reading

· 10h · on MSN

FDA Investigates Death of Boy Who Got Sarepta’s Gene Therapy

US FDA Investigates Third Death After Treatment With Sarepta's Gene Therapy Elevidys

BioPharma Dive7d

Sarepta reports patient death in limb-girdle trial, compounding concerns on gene therapy risks

The death of a 51-year-old man in the study follows two other deaths of Duchenne patients treated with Sarepta’s marketed ...

MIT Technology Review1d

The deadly saga of the controversial gene therapy Elevidys

The drug, which was designed to treat Duchenne muscular dystrophy, has been linked to the deaths of two teenage boys.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results